104 related articles for article (PubMed ID: 14973551)
1. The cooperation of B-Myb with the coactivator p300 is orchestrated by cyclins A and D1.
Schubert S; Horstmann S; Bartusel T; Klempnauer KH
Oncogene; 2004 Feb; 23(7):1392-404. PubMed ID: 14973551
[TBL] [Abstract][Full Text] [Related]
2. Regulation of B-Myb activity by cyclin D1.
Horstmann S; Ferrari S; Klempnauer KH
Oncogene; 2000 Jan; 19(2):298-306. PubMed ID: 10645009
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
Bessa M; Saville MK; Watson RJ
Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
[TBL] [Abstract][Full Text] [Related]
5. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
Saville MK; Watson RJ
Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1-dependent regulation of B-myb activity in early stages of neuroblastoma differentiation.
Cesi V; Tanno B; Vitali R; Mancini C; Giuffrida ML; Calabretta B; Raschellà G
Cell Death Differ; 2002 Nov; 9(11):1232-9. PubMed ID: 12404122
[TBL] [Abstract][Full Text] [Related]
7. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.
Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T
J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931
[TBL] [Abstract][Full Text] [Related]
8. PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.
Santilli G; Cervellera MN; Johnson TK; Lewis RE; Iacobelli S; Sala A
Oncogene; 2001 Dec; 20(57):8167-74. PubMed ID: 11781832
[TBL] [Abstract][Full Text] [Related]
9. B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107.
Joaquin M; Bessa M; Saville MK; Watson RJ
Oncogene; 2002 Nov; 21(52):7923-32. PubMed ID: 12439743
[TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53.
Dornan D; Eckert M; Wallace M; Shimizu H; Ramsay E; Hupp TR; Ball KL
Mol Cell Biol; 2004 Nov; 24(22):10083-98. PubMed ID: 15509808
[TBL] [Abstract][Full Text] [Related]
11. An alternatively spliced isoform of B-Myb is a transcriptional inhibitor.
Horstmann S; Ferrari S; Klempnauer KH
Oncogene; 2000 Nov; 19(48):5428-34. PubMed ID: 11114719
[TBL] [Abstract][Full Text] [Related]
12. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
Petrovas C; Jeay S; Lewis RE; Sonenshein GE
Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
[TBL] [Abstract][Full Text] [Related]
13. Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb.
Bartsch O; Horstmann S; Toprak K; Klempnauer KH; Ferrari S
Eur J Biochem; 1999 Mar; 260(2):384-91. PubMed ID: 10095772
[TBL] [Abstract][Full Text] [Related]
14. Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis.
Albanese C; D'Amico M; Reutens AT; Fu M; Watanabe G; Lee RJ; Kitsis RN; Henglein B; Avantaggiati M; Somasundaram K; Thimmapaya B; Pestell RG
J Biol Chem; 1999 Nov; 274(48):34186-95. PubMed ID: 10567390
[TBL] [Abstract][Full Text] [Related]
15. Transactivation mediated by B-Myb is dependent on TAF(II)250.
Bartusel T; Klempnauer KH
Oncogene; 2003 May; 22(19):2932-41. PubMed ID: 12771944
[TBL] [Abstract][Full Text] [Related]
16. The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.
Li X; McDonnell DP
Mol Cell Biol; 2002 Jun; 22(11):3663-73. PubMed ID: 11997503
[TBL] [Abstract][Full Text] [Related]
17. Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway.
Charrasse S; Carena I; Brondani V; Klempnauer KH; Ferrari S
Oncogene; 2000 Jun; 19(26):2986-95. PubMed ID: 10871850
[TBL] [Abstract][Full Text] [Related]
18. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
Huang S; Qiu Y; Stein RW; Brandt SJ
Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the transactivation domain of B-Myb with the TAZ2 domain of the coactivator p300: molecular features and properties of the complex.
Oka O; Waters LC; Strong SL; Dosanjh NS; Veverka V; Muskett FW; Renshaw PS; Klempnauer KH; Carr MD
PLoS One; 2012; 7(12):e52906. PubMed ID: 23300815
[TBL] [Abstract][Full Text] [Related]
20. Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules.
Facchinetti V; Loffarelli L; Schreek S; Oelgeschläger M; Lüscher B; Introna M; Golay J
Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):729-36. PubMed ID: 9210395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
